BIO-RAD LABORATORIES, INC. — Director's Dealing 2020

Aug 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-08-19

Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-19	Bio-Rad A Common Stock	M	3500	$84.57	Acquired	15935	Direct
2020-08-19	Bio-Rad A Common Stock	M	3500	$98.04	Acquired	19435	Direct
2020-08-19	Bio-Rad A Common Stock	M	3250	$107.32	Acquired	22685	Direct
2020-08-19	Bio-Rad A Common Stock	M	3200	$117.00	Acquired	25885	Direct
2020-08-19	Bio-Rad A Common Stock	M	3000	$119.54	Acquired	28885	Direct
2020-08-19	Bio-Rad A Common Stock	M	2000	$139.56	Acquired	30885	Direct
2020-08-19	Bio-Rad A Common Stock	M	1200	$160.37	Acquired	32085	Direct
2020-08-19	Bio-Rad A Common Stock	M	1000	$215.98	Acquired	33085	Direct
2020-08-19	Bio-Rad A Common Stock	M	500	$326.15	Acquired	33585	Direct
2020-08-19	Bio-Rad A Common Stock	S	315	$517.64	Disposed	33270	Direct
2020-08-19	Bio-Rad A Common Stock	S	5392	$518.76	Disposed	27878	Direct
2020-08-19	Bio-Rad A Common Stock	S	1133	$519.89	Disposed	26745	Direct
2020-08-19	Bio-Rad A Common Stock	S	5668	$520.94	Disposed	21077	Direct
2020-08-19	Bio-Rad A Common Stock	S	339	$521.86	Disposed	20738	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-19	Non-Qualified Stock Option (right to buy)	$84.57	M	3500	Disposed	2020-09-08	Bio-Rad A Common Stock (3500)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$98.04	M	3500	Disposed	2021-11-04	Bio-Rad A Common Stock (3500)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$107.32	M	3250	Disposed	2022-09-12	Bio-Rad A Common Stock (3250)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$117.00	M	3200	Disposed	2023-09-11	Bio-Rad A Common Stock (3200)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$119.54	M	3000	Disposed	2024-09-10	Bio-Rad A Common Stock (3000)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$139.56	M	2000	Disposed	2025-09-11	Bio-Rad A Common Stock (2000)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$160.37	M	1200	Disposed	2026-09-08	Bio-Rad A Common Stock (1200)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$215.98	M	1000	Disposed	2027-09-05	Bio-Rad A Common Stock (1000)	Direct
2020-08-19	Non-Qualified Stock Option (right to buy)	$326.15	M	500	Disposed	2028-09-04	Bio-Rad A Common Stock (500)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.34 to $518.33, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.38 to $519.25, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.39 to $520.37, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.51 to $521.51, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.73 to $522.05, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The option vests in five equal annual installments beginning on September 8, 2011.

F7: The option vests in five equal annual installments beginning on November 4, 2012.

F8: The option vests in five equal annual installments beginning on September 12, 2013.

F9: The option vests in five equal annual installments beginning on September 11, 2014.

F10: The option vests in five equal annual installments beginning on September 10, 2015.

F11: The option vests in five equal annual installments beginning on September 11, 2016.

F12: The option vests in five equal annual installments beginning on September 8, 2017.

F13: The option vests in five equal annual installments beginning on September 5, 2018.

F14: The option vests in five equal annual installments beginning on September 4, 2019.